Jamey Millar, executive vice president, US operations of Novo Nordisk, reacts to Eli Lilly’s once-daily weight-loss pill, called Foundayo, winning FDA approval on Bloomberg The Close. (Source: Bloomberg)
Jamey Millar, executive vice president, US operations of Novo Nordisk, reacts to Eli Lilly’s once-daily weight-loss pill, called Foundayo, winning FDA approval on "Bloomberg The Close." (Source: Bloomberg)
Same desk, different stories
April’s full Pink Moon lit up skies worldwide, rising beside bright star Spica in Virgo and marking the “Paschal Moon” that sets the date of Easter.
NASA’s Artemis II has launched astronauts around the moon for the first time since 1972 — the first step toward a planned lunar landing in 2028.
Looking for help with today's NYT Strands puzzle? Here's an extra hint to help you uncover the right words, as well as all of today's answers and Spangram.
The Indian rupee faces renewed pressure amid weak capital flows, high fuel prices and global uncertainty. Neeraj Gambhir, Executive Director at Axis Bank, spoke with Haslinda Amin on Insight with Haslinda Amin about…
Ecommerce giant is trying to catch up with SpaceX’s low Earth orbit internet service
Asian equities were primed for early gains Thursday after US stocks climbed and oil prices fell in a sign of rising optimism the Iran war may be nearing a conclusion.